Skip to main content
. 2015 Sep 5;6(35):38398–38409. doi: 10.18632/oncotarget.5049

Table 2. Pooled measures on the relation of breastfeeding and EC.

Heterogeneity
Subgroup Number of studies RR (95%CI) I2 (%) P value Article included
All 15 0.74(0.58 to 0.95) 64.9 0.00 18–32
Ever/never 14 0.88(0.72 to 1.06) 64.0 0.00 18–31
Study region
 Asia 5 0.57 (0.37 to 0.87) 47.6 0.11 23,27,28,30,31
 Europe 4 1.00 (0.66 to 1.53) 63.9 0.04 19,26,29,32
 North America 5 0.82 (0.60 to 1.13) 56.1 0.06 18,20,22,24,25,
 Other 1 0.23 (0.08 to 0.66) - - 21
Study design
 Cohort study 3 0.62(0.41 to 0.94) 36.5 0.21 19,27,28
 Case-control study 12 0.78(0.59 to 1.04) 67.9 0.00 18,20–26,29–32
Adjustment for hormone use
 Yes 5 0.63(0.41 to 0.97) 61.1 0.04 18,22,25,26,28
 No 9 0.77(0.58 to 1.03) 67.4 0.00 19–21,23, 24,27,29–31
Adjustment for oral contraceptive use
 Yes 5 0.72(0.44 to 1.19) 74.6 0.00 18,26,28,29,31
 No 9 0.71(0.54 to 0.93) 58.0 0.02 19–25,27,30
Adjustment for body mass index
 Yes 8 0.65(0.44 to 0.96) 74.7 0.00 19,22,23, 26,28–31
 No 7 0.83(0.63 to 1.08) 41.4 0.13 18,20,21, 24,25,27
Adjustment for menarche age
 Yes 5 0.70(0.42 to 1.17) 76.7 0.00 20,21,26,28,29
 No 9 0.71(0.55 to 0.92) 51.6 0.04 18,19,22–25,27,30,31
Adjustment for menopausal status
 Yes 5 0.65(0.38 to 1.11) 82.6 0.00 20,22,23,28,29
 No 9 0.76(0.60 to 0.97) 41.2 0.09 18,19,21, 24–27,30,31